Please wait while the formulary information is being retrieved.
THALLOUS CHLORIDE TL-201 (THALLOUS CHLORIDE TL-201)
- Myocardial perfusion imaging adjunct
- Parathyroid hyperactivity localization
37 MBq/mL (1 mCi/mL) intravenous solution
- Dosage information is not available
74 MBq/mL (2 mCi/mL) intravenous solution
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- Lactating mother
Contraindicated
- None
Severe
Moderate
- None
THALLOUS CHLORIDE TL-201 (THALLOUS CHLORIDE TL-201)
- Myocardial perfusion imaging adjunct
- Parathyroid hyperactivity localization
- None
- None
More Frequent
Severe
Less Severe
- None
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Extravasation injury
- Hypotension
Less Severe
- Blurred vision
- Chills
- Conjunctivitis
- Diarrhea
- Dyspnea
- Fever
- Flushing
- Hyperhidrosis
- Injection site sequelae
- Nausea and vomiting
- Pruritus of skin
- Skin rash
- Tremor
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Thallous chloride Tl-201
Safety and efficacy not established.
- 1 Day – 18 Years
- Safety and efficacy not established.
Thallous Chloride Ti 201
- Severity Level:
C
- Additional Notes: Insufficient data available for use in humans and animals
Contraindicated
Thallous Chloride Ti 201
Mfr recommends substituting formula feedings for breastfeeding
| General | Excretion Potential | Effect on Infant | Notes |
| Drug should not be given to breast feeding mothers | Excreted | Not known; no or inclusive data | Mfr recommends substituting formula feedings for breastfeeding |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Formulary Reference Tool